Could a simple amino acid shorten diabetic emergencies?
NCT ID NCT07167693
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tests whether a single infusion of arginine hydrochloride, a natural amino acid, can help people with type 2 diabetes recover faster from diabetic ketoacidosis (DKA), a serious complication. Sixty adults arriving at emergency rooms with DKA will receive either arginine or a placebo alongside standard care. The goal is to see if arginine boosts the body's own insulin production, clearing ketones more quickly and reducing the need for additional insulin.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
arginine hydrochloride
What this could lead to
If it works, this could offer a simple, safe way to shorten hospital stays and reduce insulin needs during diabetic ketoacidosis in type 2 diabetes.
What could go wrong
This is an early phase 1/2 trial with only 60 participants, so results may not apply broadly. The infusion may cause temporary side effects like flushing or nausea, and benefits are not guaranteed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERGLYCAEMIA (DIABETIC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Detroit Medical Center
RECRUITINGDetroit, Michigan, 48201, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••